"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
| Descriptor ID |
D007167
|
| MeSH Number(s) |
E02.095.465.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 3 | 3 |
| 2000 | 4 | 2 | 6 |
| 2001 | 2 | 5 | 7 |
| 2002 | 5 | 6 | 11 |
| 2003 | 5 | 5 | 10 |
| 2004 | 5 | 4 | 9 |
| 2005 | 6 | 2 | 8 |
| 2006 | 2 | 2 | 4 |
| 2007 | 4 | 3 | 7 |
| 2008 | 3 | 7 | 10 |
| 2009 | 12 | 5 | 17 |
| 2010 | 8 | 7 | 15 |
| 2011 | 9 | 7 | 16 |
| 2012 | 3 | 9 | 12 |
| 2013 | 9 | 7 | 16 |
| 2014 | 17 | 11 | 28 |
| 2015 | 7 | 7 | 14 |
| 2016 | 14 | 6 | 20 |
| 2017 | 21 | 13 | 34 |
| 2018 | 17 | 13 | 30 |
| 2019 | 14 | 14 | 28 |
| 2020 | 25 | 16 | 41 |
| 2021 | 15 | 23 | 38 |
| 2022 | 4 | 30 | 34 |
| 2023 | 2 | 22 | 24 |
| 2024 | 12 | 16 | 28 |
| 2025 | 10 | 4 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers. J Surg Oncol. 2025 Oct; 132(5):789-809.
-
Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy. Cell Rep Med. 2025 Sep 16; 6(9):102324.
-
Clinical phenotype and outcomes in autoimmune encephalitis after herpes simplex virus encephalitis: A systematic review and meta-analysis. J Infect. 2025 Sep; 91(3):106566.
-
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia. Blood. 2025 Jul 24; 146(4):437-455.
-
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma. J Neurooncol. 2025 Oct; 175(1):453-461.
-
A Multi-Threshold Micelle Improves Tumor Accumulation and STING Immunotherapy. J Am Chem Soc. 2025 Jun 11; 147(23):19547-19558.
-
Novel approaches to prevent or cure allergic diseases. Curr Opin Immunol. 2025 Aug; 95:102569.
-
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas. Blood Adv. 2025 Apr 08; 9(7):1658-1669.
-
Current and emerging treatment perspectives for adults with Waldenstr?m macroglobulinemia. Expert Rev Anticancer Ther. 2025 May; 25(5):485-497.
-
Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation. Front Immunol. 2025; 16:1529707.